Is a total dose of 54 Gy with radiochemotherapy sufficient for treatment of intermediate-risk volumes in nasopharyngeal cancer?

Published in: Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] (2023)

These retrospective data suggest that a dose reduction may be possible for intermediate-risk volumes, especially for the primary site.

Keyphrases